Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers

Breast cancers are commonly associated with an immunosuppressive microenvironment responsible for tumor escape from anti-cancer immunity. Cells of the myeloid lineage account for a major part of this tumor-promoting landscape. These myeloid cells are composed of heterogeneous subsets at different st...

Full description

Bibliographic Details
Main Authors: Céline Blaye, Thomas Boyer, Florent Peyraud, Charlotte Domblides, Nicolas Larmonier
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.838040/full
_version_ 1818199804700786688
author Céline Blaye
Céline Blaye
Thomas Boyer
Florent Peyraud
Charlotte Domblides
Charlotte Domblides
Nicolas Larmonier
Nicolas Larmonier
author_facet Céline Blaye
Céline Blaye
Thomas Boyer
Florent Peyraud
Charlotte Domblides
Charlotte Domblides
Nicolas Larmonier
Nicolas Larmonier
author_sort Céline Blaye
collection DOAJ
description Breast cancers are commonly associated with an immunosuppressive microenvironment responsible for tumor escape from anti-cancer immunity. Cells of the myeloid lineage account for a major part of this tumor-promoting landscape. These myeloid cells are composed of heterogeneous subsets at different stages of differentiation and have traditionally been described by their cardinal ability to suppress innate and adaptive anticancer immunity. However, evidence has accumulated that, beyond their immunosuppressive properties, breast cancer-induced myeloid cells are also equipped with a broad array of “non-immunological” tumor-promoting functions. They therefore represent major impediments for anticancer therapies, particularly for immune-based interventions. We herein analyze and discuss current literature related to the versatile properties of the different myeloid cell subsets engaged in breast cancer development. We critically assess persisting difficulties and challenges in unequivocally discriminate dedicated subsets, which has so far prevented both the selective targeting of these immunosuppressive cells and their use as potential biomarkers. In this context, we propose the concept of IMCGL, “pro-tumoral immunosuppressive myeloid cells of the granulocytic lineage”, to more accurately reflect the contentious nature and origin of granulocytic cells in the breast tumor microenvironment. Future research prospects related to the role of this myeloid landscape in breast cancer are further considered.
first_indexed 2024-12-12T02:27:35Z
format Article
id doaj.art-29cd9e45aecc47139b06158bfbbd499f
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-12T02:27:35Z
publishDate 2022-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-29cd9e45aecc47139b06158bfbbd499f2022-12-22T00:41:31ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-03-011310.3389/fimmu.2022.838040838040Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast CancersCéline Blaye0Céline Blaye1Thomas Boyer2Florent Peyraud3Charlotte Domblides4Charlotte Domblides5Nicolas Larmonier6Nicolas Larmonier7Centre National de la Recherche Scientific (CNRS) Unité Mixte de Recherche (UMR) 5164, ImmunoConcEpT, Bordeaux, FranceDepartment of Medical Oncology, Institut Bergonié, Bordeaux, FranceCentre National de la Recherche Scientific (CNRS) Unité Mixte de Recherche (UMR) 5164, ImmunoConcEpT, Bordeaux, FranceCentre National de la Recherche Scientific (CNRS) Unité Mixte de Recherche (UMR) 5164, ImmunoConcEpT, Bordeaux, FranceCentre National de la Recherche Scientific (CNRS) Unité Mixte de Recherche (UMR) 5164, ImmunoConcEpT, Bordeaux, FranceService d’Oncologie Médicale, Centre Hospitalo-Universitaire (CHU) Bordeaux, Bordeaux, FranceCentre National de la Recherche Scientific (CNRS) Unité Mixte de Recherche (UMR) 5164, ImmunoConcEpT, Bordeaux, FranceDepartment of Biological and Medical Sciences, University of Bordeaux, Bordeaux, FranceBreast cancers are commonly associated with an immunosuppressive microenvironment responsible for tumor escape from anti-cancer immunity. Cells of the myeloid lineage account for a major part of this tumor-promoting landscape. These myeloid cells are composed of heterogeneous subsets at different stages of differentiation and have traditionally been described by their cardinal ability to suppress innate and adaptive anticancer immunity. However, evidence has accumulated that, beyond their immunosuppressive properties, breast cancer-induced myeloid cells are also equipped with a broad array of “non-immunological” tumor-promoting functions. They therefore represent major impediments for anticancer therapies, particularly for immune-based interventions. We herein analyze and discuss current literature related to the versatile properties of the different myeloid cell subsets engaged in breast cancer development. We critically assess persisting difficulties and challenges in unequivocally discriminate dedicated subsets, which has so far prevented both the selective targeting of these immunosuppressive cells and their use as potential biomarkers. In this context, we propose the concept of IMCGL, “pro-tumoral immunosuppressive myeloid cells of the granulocytic lineage”, to more accurately reflect the contentious nature and origin of granulocytic cells in the breast tumor microenvironment. Future research prospects related to the role of this myeloid landscape in breast cancer are further considered.https://www.frontiersin.org/articles/10.3389/fimmu.2022.838040/fullbreast cancertumor-promoting myeloid cellsimmunosuppressionimmunotherapiestumor microenvironment
spellingShingle Céline Blaye
Céline Blaye
Thomas Boyer
Florent Peyraud
Charlotte Domblides
Charlotte Domblides
Nicolas Larmonier
Nicolas Larmonier
Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
Frontiers in Immunology
breast cancer
tumor-promoting myeloid cells
immunosuppression
immunotherapies
tumor microenvironment
title Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
title_full Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
title_fullStr Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
title_full_unstemmed Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
title_short Beyond Immunosuppression: The Multifaceted Functions of Tumor-Promoting Myeloid Cells in Breast Cancers
title_sort beyond immunosuppression the multifaceted functions of tumor promoting myeloid cells in breast cancers
topic breast cancer
tumor-promoting myeloid cells
immunosuppression
immunotherapies
tumor microenvironment
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.838040/full
work_keys_str_mv AT celineblaye beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT celineblaye beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT thomasboyer beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT florentpeyraud beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT charlottedomblides beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT charlottedomblides beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT nicolaslarmonier beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers
AT nicolaslarmonier beyondimmunosuppressionthemultifacetedfunctionsoftumorpromotingmyeloidcellsinbreastcancers